Cerus (CERS) Restructuring Costs (2010)

Cerus (CERS) posted Restructuring Costs of -$182000.0 for Q4 2010, up 9.45% sequentially from -$201000.0 in Q3 2010.

Cerus (CERS) Restructuring Costs (2010) Analysis & Trends

Cerus has reported Restructuring Costs for 1 years, with the latest figure at -$182000.0 in Q4 2010.

Quarterly Restructuring Costs changed N/A year-over-year to -$182000.0 in Q4 2010, while the trailing twelve-month figure through Dec 2011 was -$182000.0 (changed N/A YoY) and the FY2009 annual result came in at $841000.0, changed N/A from the prior year.
Restructuring Costs grew to -$182000.0 in Q4 2010 per CERS's latest filing, from -$201000.0 in the prior quarter.
Over five years, Restructuring Costs peaked at $132000.0 in Q2 2010 and troughed at -$201000.0 in Q3 2010.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	199.70 Bn	194.09 Bn	7.27 Bn
2	Stryker	127.31 Bn	123.83 Bn	4.50 Bn
3	Medtronic	118.93 Bn	109.71 Bn	6.41 Bn
4	Boston Scientific	73.35 Bn	72.82 Bn	3.85 Bn
5	Edwards Lifesciences	52.11 Bn	47.86 Bn	1.35 Bn
6	Dexcom	34.35 Bn	32.40 Bn	830.00 Mn
7	GE HealthCare Technologies	33.76 Bn	31.65 Bn	2.18 Bn
8	Koninklijke Philips	26.35 Bn	23.03 Bn	4.55 Bn
9	Steris	23.05 Bn	22.56 Bn	684.20 Mn
10	Cerus	559.58 Mn	503.31 Mn	29.53 Mn

Download Data